Delivery Order SPE2DB24D2010-SPE2DB25FAAQZ
- Not listed
- The Defense Logistics Agency awarded a $49,629.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 25, 2025. This is a competitively awarded, non-set-aside contract performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, representing a critical pharmaceutical commodity for military and...
- The Defense Logistics Agency awarded a $3,374.96 delivery order to AmerisourceBergen Drug Corp for ProQuad vials on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price contract represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunization protection against measles, mumps, rubella, and varicella, commonly used within military and federal...
- The Defense Logistics Agency awarded a delivery order valued at $24,814.95 to AmerisourceBergen Drug Corp for ProQuad vials on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price, competitively awarded contract is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine indicated for prevention of measles, mumps, rubella, and varicella, representing a critical pharmaceutical supply for...
- The Defense Logistics Agency awarded a delivery order valued at $1,687.48 to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, representing the type of critical medical supply that...
- The Defense Logistics Agency awarded a delivery order valued at $7,168.24 to AmerisourceBergen Drug Corp for ProQuad vials. This is a firm fixed-price, non-set-aside contract with a completion deadline of August 19, 2025, issued on July 29, 2025. ProQuad is a combination vaccine for measles, mumps, rubella, and varicella, essential for military medical readiness and troop health maintenance. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $8,354.50 under a firm fixed-price contract. The award was made on July 25, 2025, with an ultimate completion date of August 15, 2025. This is a non-set-aside, competitively awarded delivery order, with performance to take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine used for immunization against measles,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,308.68 to AmerisourceBergen Drug Corp for ProQuad vials on July 22, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price delivery order represents a competitively awarded, non-set-aside contract with performance to be completed at the contractor's Conshohocken, Pennsylvania facility. ProQuad is a combination vaccine for measles, mumps, rubella, and varicella, indicating this delivery supports...
- The Defense Logistics Agency awarded a delivery order for ProQuad vials valued at $3,374.96 to AmerisourceBergen Drug Corp on July 29, 2025, with a completion date of August 19, 2025. This firm fixed-price delivery order is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. No set-aside designation was used for this competitively awarded contract. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $1,687.48, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ProQuad vials valued at $2,740.40 with an ultimate completion date of August 19, 2025. This firm fixed price, competitively awarded delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be performed at AmerisourceBergen's...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAAQZDelivery Order
The Defense Logistics Agency awarded a $17,711.36 delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of August 25, 2025. This is a firm fixed-price, non-set-aside contract performed at the contractor's location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunization against measles, mumps, rubella, and varicella, representing a critical pharmaceutical commodity within the federal medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999, which serves as the company's primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally through December 2026. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, is a well-established federal vendor with extensive experience fulfilling competitively awarded contracts across multiple therapeutic domains for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.7k | 8/4/25 |